Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center recalls PF-Fentanyl Citrate 2 mcg/mL* & Bupivacaine HCl 0.125% in 0.9% Sodium Chloride Injection-250 mL, Rx Only Total Dose: (5
Recalled October 30, 2019 · FDA recall D-0148-2020 · Nephron Pharmaceuticals Corporation
Hazard
GMP Deviations: potential glass contamination · FDA Class II
Units
1370 bags
Sold at
Nationwide.
Description
GMP Deviations: potential glass contamination
Product
PF-Fentanyl Citrate 2 mcg/mL* & Bupivacaine HCl 0.125% in 0.9% Sodium Chloride Injection-250 mL, Rx Only Total Dose: (500 mcg/312.5 mg)/250 mL, Nephron 503B Outsourcing Facility 4500 12th St. Extension West Columbia, SC 29172 NDC: 69374-530-25
Manufacturer(s)
Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →